Tamsol Sustained Release Tablet 0.2 mg (Tamsulosin Hydrochloride)

Adult dose

Adults: Administer 0.2 mg of tamsulosin hydrochloride orally once daily after a meal. Swallow this medicine whole; do not crush or chew it. Adjust the dose as appropriate according to symptoms.

This medication should not be used in patients with a history of hypersensitivity reactions such as angioedema. Patients with orthostatic hypotension may experience worsened symptoms; therefore, it should not be administered. Patients with severely impaired liver function may have increased blood concentrations of this medication, so it is advisable not to use it. It is not administered to pregnant women or women who may become pregnant as safety has not been established. Caution is required when administering to patients with severely impaired kidney function or the elderly, as drug concentrations may increase. Care should be taken when used with antihypertensives, PDE5 inhibitors, CYP3A4 inhibitors, etc., as interactions may lead to severe hypotension. Patients currently taking alpha-1 blockers should generally avoid this medication, but it may be used with caution in necessary cases. Patients with a history of urinary syncope should also generally avoid this medication, but it may be used with caution if necessary. This medication may cause dizziness or fainting due to blood pressure reduction; therefore, if any abnormal symptoms occur during administration, it should be discontinued immediately, and appropriate measures taken. Dizziness, drowsiness, and headaches may occur as central nervous system symptoms, so caution is advised when driving or performing hazardous tasks. If any hypersensitivity reactions such as skin rash, itching, or urticaria occur, use should be stopped immediately. Gastrointestinal symptoms such as nausea, vomiting, constipation, or diarrhea may occur, so caution is advised. If there are signs of liver dysfunction or jaundice, administration should be discontinued immediately, and medical attention sought. This medication carries a risk of hypotension with high doses, so the prescribed dosage should be adhered to. During administration, blood pressure changes due to changes in posture should be closely monitored, particularly being cautious of dizziness when standing. This medication is not a causal treatment but is intended for symptom relief; if ineffective, alternative treatment methods should be considered. Patients with sulfonamide allergies may experience allergic reactions when taking this medication, so caution is needed. Capsules or sustained-release tablets should not be chewed or crushed and must be taken with water, and removal from the PTP packaging is necessary to prevent esophageal injury. It should be stored out of reach of children, and it is advisable not to transfer it to another container. Safety and efficacy have not been established for pregnant or breastfeeding women and children under 18 years of age, so it is not used.

• Syncope
• loss of consciousness
• dizziness
• balance impairment
• orthostatic dizziness
• headache
• drowsiness
• nervousness
• insomnia
• decreased libido

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Furthermore, it is safest to store it at room temperature between 1 and 30 degrees Celsius and not in extremely hot or cold conditions.

Appearance

A white, round sustained-release tablet with light yellow spots.

Package unit

30 tablets/box [10 tablets/PTP x 3 pieces]